[Federal Register Volume 74, Number 176 (Monday, September 14, 2009)]
[Notices]
[Page 46998]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-22000]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of the Director, National Institutes of Health; Notice of 
Public Forums

    Notice is hereby given of two forums of the working groups of the 
NIH Scientific Management Review Board: Deliberating Organizational 
Changes and Effectiveness Working Group and Substance Use, Abuse and 
Addition Working Group. The forums will serve as the first among a 
series of sessions for gathering information on the agency's 
organizational structure and recommendations for enhancing the NIH 
mission through greater agency flexibility and responsiveness.
    The forums will be open to the public, with attendance limited to 
space available. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should notify the Contact Person listed below in 
advance of the meeting.
    The input from these meetings will be summarized in a report that 
will be presented to the Scientific Management Review Board in open 
session at an upcoming meeting.

    Name of Committee: Substance Use, Abuse, and Addiction Working 
Group of the Scientific Management Review Board.
    Date: September 23, 2009.
    Open: 8 a.m. to 3 p.m.
    Agenda: Presentation and discussion will include an overview of 
the science of substance use, abuse, and addiction and the public 
health needs in this area of research.
    Place: National Institutes of Health, Building 60, Chapel and 
Lecture Hall, 9000 Rockville Pike, Bethesda, MD 20892.

    Name of Committee: Deliberating Organizational Change and 
Effectiveness Working Group of the Scientific Management Review 
Board.
    Date: September 24, 2009.
    Open: 8 a.m. to 3 p.m.
    Agenda: Presentations and discussion will include an overview of 
NIH mission and function from scientific and stakeholder 
perspectives, including elaboration upon the principles and 
attributes fundamental to its success.
    Place: National Institutes of Health, Building 60, Chapel and 
Lecture Hall, 9000 Rockville Pike, Bethesda, MD 20892.
    Contact Person: Dr. Lyric Jorgenson, PhD, NIH-AAAS Science and 
Technology Policy Fellow, Office of Science Policy, Office of the 
Director, NIH, National Institutes of Health, Building 1, Room 218, 
MSC 0166, 9000 Rockville Pike, Bethesda, MD 20892, 
<a href="/cdn-cgi/l/email-protection#6d1e001f0f2d000c040143030405430a021b"><span class="__cf_email__" data-cfemail="45362837270528242c296b2b2c2d6b222a33">[email protected]</span></a>, (301) 496-6837.
    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person. The meeting will also be 
webcast. The draft meeting agenda and other information about the 
SMRB, including information about access to the webcast, will be 
available at http://smrb.od.nih.gov.
    In the interest of security, NIH has instituted stringent 
procedures for entrance onto the NIH campus. All visitor vehicles, 
including taxis, hotel, and airport shuttles will be inspected 
before being allowed on campus. Visitors will be asked to show one 
form of identification (for example, a government-issued photo ID, 
driver's license, or passport) and to state the purpose of their 
visit.

    Dated: August 28, 2009.
Lynn Hudson,
Acting Director, Office of Biotechnology Activities.
[FR Doc. E9-22000 Filed 9-11-09; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>